- Pfizer Inc PFE.N has started a pilot delivery program for its experimental COVID-19 vaccine.
- It selected Rhode Island, Texas, New Mexico, and Tennessee for the experimental delivery program.
- The company demands to have adequate security data on the vaccine.
THDNewsDesk: Pfizer Inc PFE.N has started a pilot delivery program for its experimental COVID-19 vaccine in four U.S. states. The U.S. drugmaker attempts to discuss administration hurdles challenging the vaccine’s ultra-cold storage requirements.
Pfizer’s vaccine, which was revealed to be more than 90% efficient in controlling COVID-19 based on primary data, must be exported and stored at -70 degrees Celsius (minus 94°F), significantly below the standard for vaccines of 2-8 degrees Celsius (36-46°F).
On Monday, Pfizer stated that “We are hopeful that results from this vaccine delivery pilot will serve as the model for other U.S. states and international governments, as they prepare to implement effective COVID-19 vaccine programs.”
It selected Rhode Island, Texas, New Mexico, and Tennessee for the schedule after considering their variations in overall size, heterogeneity of populations, immunization infrastructure, and a demand to reach individuals in various urban and rural backgrounds.
Pfizer stated that the four states would not get vaccine doses before the other States because of the pilot, nor will they obtain any differential consideration.
The company demands adequate security data on the vaccine from the continuous large scale late-stage tests by the third week of November before advancing to practice for Emergency Use Authorization (EUA).